UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000011392 |
|---|---|
| Receipt number | R000012936 |
| Scientific Title | Investigation on efficacy of memantine in patients with Alzheimer's disease. |
| Date of disclosure of the study information | 2013/08/12 |
| Last modified on | 2017/11/09 11:42:31 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation on efficacy of memantine in patients with Alzheimer's disease.
Acronym
Efficacy of memantine in patients with Alzheimer's disease.
Scientific Title
Investigation on efficacy of memantine in patients with Alzheimer's disease.
Scientific Title:Acronym
Efficacy of memantine in patients with Alzheimer's disease.
Region
| Japan |
Condition
Condition
Alzheimer's disease
Classification by specialty
| Neurology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study aims to investigate the efficacy of memantine in patients with Alzheimer's disease.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Changes from baseline at week 48 on NPI
Key secondary outcomes
Changes from baseline at week 48 on MMSE, TYM-J, Zarit Burden Interview
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
12-month study evaluated the treatment effect and response of memantine in AD patients.
Interventions/Control_2
12-month study evaluated the treatment effect and response of memantine in AD patients.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients 1) who are Alzheimer's disease, 2) MMSE 0-20, 3) CDR 1-3, FAST stage 2-7, 3) TYM-J 0-34/50, 4) who understand the points of this study and give informed-consent in literature.
Key exclusion criteria
1)Patients who correspond to the administration contraindication o the obhective drug.
2)Patients inadequate for the study.
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yumiko Kutoku |
Organization
Kawasaki Medical School
Division name
Neurology
Zip code
Address
577 Matsushima, Kurashiki Okayama 701-0192, Japan
TEL
086-462-1111
kutoku@med.kawasaki-m.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yumiko Kutoku |
Organization
Kawasaki Medical School
Division name
neurology
Zip code
Address
577 Matsushima, Kurashiki Okayama 701-0192, Japan
TEL
086-462-1111
Homepage URL
kutoku@med.kawasaki-m.ac.jp
Sponsor or person
Institute
Kawasaki Medical School
Institute
Department
Personal name
Funding Source
Organization
Kawasaki Medical School
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 08 | Month | 12 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2013 | Year | 08 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2013 | Year | 08 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2013 | Year | 08 | Month | 06 | Day |
Last modified on
| 2017 | Year | 11 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012936
